The GLP is committed to full transparency. Download and review our 2019 Annual Report

Stem cells transplanted into 1st Macular-Degeneration patient

| October 5, 2012
This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

StemCells Inc. (STEM) said it transplanted neural stem cells into its first patient with dry age-related macular degeneration, pushing forward its Phase I/II clinical trial.

View the original article here: StemCells Transplants Stem Cells into 1st Macular-Degeneration Patient – Wall Street Journal

Share via
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.
Send this to a friend